The MES-like phenotype has been recently associated with resistance to ALK inhibitors (ALKi) due to the absence of ALK expression even in presence of tumour-driving ALK mutations, suggesting a role of ADRN-to-MES conversion in relapse (35). This evidence concerns the gene ALK and neoplasm.